Search clinical trials for: PM060184

Total 6 results

PharmaMar

Completed

Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard Treatment

Advanced Colorectal Cancer

United States, Canada, Spain
PharmaMar

Completed

Study of PM060184 in Patients With Advanced Solid Tumors

Solid Tumors

United States
PharmaMar

Terminated

A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma

Lymphoma | Solid Tumors

United States
PharmaMar

Terminated

Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy

Endometrial Cancer | Uterine Cervical Cancer

United States
PharmaMar

Completed

Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy

Ewing's Sarcoma | Primitive Neuroectodermal Tumor (PNET) | Askin's Tumor of the Chest Wall | Extraosseous Ewing's Sarcoma (EOE)

France, United States, Italy
PharmaMar

Completed

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

Solid Tumors

Spain, United States

3

Subscribe